| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1390834A Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506787 Aids therapy |
| 01/14/2003 | US6506786 HIV protease inhibitors based on amino acid derivatives |
| 01/14/2003 | US6506785 Establishing the status of the mammal as presently or prospectively being in early stages of degeneration of articular cartilage or subchondral bone in one or more joinsts, administering a xanthine chondroprotective compound |
| 01/14/2003 | US6506763 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity |
| 01/14/2003 | US6506758 Indole derivatives useful A.O. for the treatment of osteoporosis |
| 01/09/2003 | WO2003003482A1 Organic light emitting diode devices using thermostable hole-injection and hole-transport compounds |
| 01/09/2003 | WO2003002545A1 Peptoid compounds |
| 01/09/2003 | WO2003002533A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 01/09/2003 | WO2003002532A1 Cyclic diamine compounds having fused-ring groups |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003002491A2 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 01/09/2003 | WO2003002255A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/09/2003 | WO2002057231A3 Benz(g) indoles and their use as spla2 inhibitors |
| 01/09/2003 | US20030009055 Process for the preparation of 1-aminomethyl-1- cyclohexaneacetic acid |
| 01/09/2003 | US20030009036 To produce polymers; cancer therapy |
| 01/09/2003 | US20030009033 Substituted condensation products of N-benzyl-3-indenylacent amides with heterocyclic aldehydes for neoplasia |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | US20030008913 For controlling harmful insects, acarids and nematodes |
| 01/09/2003 | US20030008911 Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| 01/09/2003 | US20030008909 For therapy of uterine myometrial fibroids, endometriosis, benign prostatic hypertrophy; carcinomas and adenocarcinomas of endometrium, ovary, breast, colon, prostate, pituitary, meningioma and other hormone-dependent tumors |
| 01/09/2003 | US20030008900 Compounds and compositions for delivering active agents |
| 01/09/2003 | US20030008898 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation |
| 01/09/2003 | US20030008895 Prostaglandin agonists |
| 01/09/2003 | US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives |
| 01/09/2003 | US20030008360 Microorganisms for use in the generation of preferential cyclopentene |
| 01/09/2003 | US20030008234 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
| 01/09/2003 | US20030005525 Composition for dyeing keratin fibers with a cationic direct dye and a thickening polymer |
| 01/08/2003 | EP1273343A1 Method of separating imide compound |
| 01/08/2003 | EP1273330A1 Sublimation purifying method and apparatus |
| 01/08/2003 | EP1272900A2 High speed photothermographic materials containing tellurium compounds and methods of using same |
| 01/08/2003 | EP1272468A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 01/08/2003 | EP1272467A1 Cathepsin cysteine protease inhibitors |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1124819B1 Method of lithiating five-membered heterocycles |
| 01/08/2003 | EP0863878B1 Cyclic nitrones and pharmaceutical compositions containing them |
| 01/08/2003 | CN1390214A New phenylpiperazines |
| 01/08/2003 | CN1390213A Aryloxy propanolamines for improving livestock production |
| 01/07/2003 | US6504036 2- and 2.5-substituted phenylketoenols |
| 01/07/2003 | US6503998 Nonlinear Optical (nlo) materials, sulfon-diol-ether derivatives |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | US6503939 Combination regimens using 3,3-substituted indoline derivatives |
| 01/07/2003 | US6503938 Treatment of estrogen related disease or tumor, including prostatic hyperplasia, breast cancer, endometrial carcinoma, anovulatory infertility, melanoma or osteoporosis |
| 01/07/2003 | US6503907 Indole and dihydroindole derivatives |
| 01/07/2003 | US6503900 [1,4]diazepino [6,7,1-jk ]carbazoles and derivatives |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000680A1 Diamine derivatives |
| 01/03/2003 | WO2003000657A1 Diamine derivatives |
| 01/03/2003 | WO2003000649A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000289A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | WO2003000253A1 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000252A1 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors |
| 01/03/2003 | WO2003000251A1 Novel idolinones and uses thereof |
| 01/03/2003 | WO2003000247A1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2002008187A9 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/03/2003 | WO2002001653A3 Organic light emitting diode devices using aromatic amine compounds with high and tunable glass transition temperatures |
| 01/03/2003 | CA2450758A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | CA2450174A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/02/2003 | WO2002002529A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 01/02/2003 | US20030004351 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 01/02/2003 | US20030004181 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions |
| 01/02/2003 | US20030004162 Antidiabetic agents; dietetics |
| 01/02/2003 | US20030004156 Anticholesterol agents; cardiovascular disorders; antidiabetic agents; antiproliferative agents |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | US20030004149 Antiangiogenic compounds and an assay for inhibitors of cell invasion |
| 01/02/2003 | US20030004138 Hypoglycemic agents; antidiabetic agents; dietetics |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | EP1270565A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives |
| 01/02/2003 | EP1270562A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof |
| 01/02/2003 | EP1270557A1 Ethylenediamine derivatives |
| 01/02/2003 | EP1270554A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 01/02/2003 | EP1268479A1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
| 01/02/2003 | EP1268478A2 Phenyl-substituted imidazopyridines |
| 01/02/2003 | EP1268441A1 An intermediate and process for its synthesis |
| 01/02/2003 | EP1268425A2 Carbamate caspase inhibitors and uses thereof |
| 01/02/2003 | EP1268424A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/02/2003 | EP1268423A1 Indole derivatives as mcp-1 receptor antagonists |
| 01/02/2003 | EP1268422A1 Indoles for treating diseases that can be treated using thyroid hormones |
| 01/02/2003 | EP1268421A2 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 01/02/2003 | EP1268404A1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2003 | EP1268398A2 Novel method for synthesis of n- (s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 01/02/2003 | EP1268051A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 01/02/2003 | EP1267878A2 Compounds with 5-ht activity useful for controlling visual field loss |
| 01/02/2003 | EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 01/02/2003 | EP1083897A4 Hiv integrase inhibitors |
| 01/02/2003 | EP1053246B1 Beta-sheet mimetics and methods relating to the use thereof |
| 01/02/2003 | EP0891341B1 1,3,4-oxadiazine derivatives and their use as pesticides |
| 01/02/2003 | CA2414726A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 12/31/2002 | US6500854 Chondrongenesis promotors and indolin-2-one derivatives |
| 12/31/2002 | US6500853 Enzyme inhibitors such as 4-((1-benzhydryl-5-(((butylamino)-carbonyl)amino)-1h-indol-3-yl)methyl)-3 -methoxybenzoic acid used as antiinflammatory agents for prophylaxis of arthritis, inflammatory bowel disease or asthma |
| 12/31/2002 | US6500852 Inhibitors of bacterial NAD synthetase |
| 12/31/2002 | US6500851 Antithrombotic agents |